|
| 37767572 | Concurrent peripheral T-cell lymphoma and T-cell lymphoblastic leukemia/lymphoma with identical <i>STIL</i>::<i>TAL1</i> fusion events. | Haematologica | 2024 |
| 37890156 | Acute myeloid leukemias with UBTF tandem duplications are sensitive to menin inhibitors. | Blood | 2024 |
| 36179268 | Description of a novel subtype of acute myeloid leukemia defined by recurrent CBFB insertions. | Blood | 2023 |
| 38014207 | <i>UBTF</i> Tandem Duplications in Pediatric MDS and AML: Implications for Clinical Screening and Diagnosis. | medRxiv | 2023 |
| 37790524 | Functional Characterization of Cooperating MGA Mutations in RUNX1::RUNX1T1 Acute Myeloid Leukemia. | Res Sq | 2023 |
| 37601875 | <i>CBFA2T3::GLIS2</i>-positive acute leukemia with RAM and mixed T/megakaryocytic phenotype. | EJHaem | 2023 |
| 37058475 | Clinical impact of minimal residual disease in blood and bone marrow of children with acute myeloid leukemia. | Blood Adv | 2023 |
| 37019972 | Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication. | Nat Commun | 2023 |
| 37283355 | Clinical and genomic characterization of an ATRA-insensitive acute promyelocytic leukemia variant with a FNDC3B::RARB fusion. | Genes Chromosomes Cancer | 2023 |
| 37406166 | Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41. | Blood Adv | 2023 |
| 37398194 | Proposal of a new genomic framework for categorization of pediatric acute myeloid leukemia associated with prognosis. | Res Sq | 2023 |
| 36689724 | SAMHD1 single nucleotide polymorphisms impact outcome in children with newly diagnosed acute myeloid leukemia. | Blood Adv | 2023 |
| 36898329 | From PROTAC to inhibitor: Structure-guided discovery of potent and orally bioavailable BET inhibitors. | Eur J Med Chem | 2023 |
| 34903620 | Phase Separation Mediates NUP98 Fusion Oncoprotein Leukemic Transformation. | Cancer Discov | 2022 |
| 36074606 | Mutant Samd9l expression impairs hematopoiesis and induces bone marrow failure in mice. | J Clin Invest | 2022 |
| 36130297 | Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia. | Blood | 2022 |
| 36123353 | Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia. | Nat Commun | 2022 |
| 35914226 | Engineering naturally occurring CD7- T cells for the immunotherapy of hematological malignancies. | Blood | 2022 |
| 35102167 | CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cells. | Nat Commun | 2022 |
| 35176137 | Integrated Genomic Analysis Identifies UBTF Tandem Duplications as a Recurrent Lesion in Pediatric Acute Myeloid Leukemia. | Blood Cancer Discov | 2022 |
| 32693409 | Molecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemia. | Blood | 2021 |
| 33823069 | Activity of venetoclax against relapsed acute undifferentiated leukemia. | Cancer | 2021 |
| 33487172 | SequencErr: measuring and suppressing sequencer errors in next-generation sequencing data. | Genome Biol | 2021 |
| 33731850 | Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells. | Leukemia | 2021 |
| 33579957 | The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms. | Nat Commun | 2021 |
| 35122027 | Chemotherapy and mismatch repair deficiency cooperate to fuel TP53 mutagenesis and ALL relapse. | Nat Cancer | 2021 |
| 34587228 | Rational biomarker development for the early and minimally invasive monitoring of AML. | Blood Adv | 2021 |
| 34778799 | Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators. | Blood Cancer Discov | 2021 |
| 34678152 | Serial assessment of measurable residual disease in medulloblastoma liquid biopsies. | Cancer Cell | 2021 |
| 34301788 | Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing. | Cancer Discov | 2021 |
| 34103329 | Enhancer Hijacking Drives Oncogenic <i>BCL11B</i> Expression in Lineage-Ambiguous Stem Cell Leukemia. | Cancer Discov | 2021 |
| 34233450 | The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy. | Haematologica | 2021 |
| 33328584 | Advances in germline predisposition to acute leukaemias and myeloid neoplasms. | Nat Rev Cancer | 2021 |
| 32171069 | Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study. | Lancet Oncol | 2020 |
| 31645648 | A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia. | Leukemia | 2020 |
| 32809242 | Safety, pharmacokinetics, and pharmacodynamics of panobinostat in children, adolescents, and young adults with relapsed acute myeloid leukemia. | Cancer | 2020 |
| 32766874 | Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies. | Blood | 2020 |
| 32300185 | Correction: A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia. | Leukemia | 2020 |
| 31246522 | Clofarabine Can Replace Anthracyclines and Etoposide in Remission Induction Therapy for Childhood Acute Myeloid Leukemia: The AML08 Multicenter, Randomized Phase III Trial. | J Clin Oncol | 2019 |
| 29500178 | TAK1 restricts spontaneous NLRP3 activation and cell death to control myeloid proliferation. | J Exp Med | 2018 |
| 29891567 | Clonal dynamics of donor-derived myelodysplastic syndrome after unrelated hematopoietic cell transplantation for high-risk pediatric B-lymphoblastic leukemia. | Cold Spring Harb Mol Case Stud | 2018 |
| 30046003 | Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes. | JCI Insight | 2018 |
| 30232126 | Donor-derived MDS/AML in families with germline <i>GATA2</i> mutation. | Blood | 2018 |
| 30262806 | Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome. | Nat Commun | 2018 |
| 30380364 | Immune Escape of Relapsed AML Cells after Allogeneic Transplantation. | N Engl J Med | 2018 |
| 27248844 | Transcriptome profiling of patient derived xenograft models established from pediatric acute myeloid leukemia patients confirm maintenance of FLT3-ITD mutation. | Leuk Lymphoma | 2017 |
| 28487541 | Germline SAMD9 mutation in siblings with monosomy 7 and myelodysplastic syndrome. | Leukemia | 2017 |
| 29146900 | The genomic landscape of pediatric myelodysplastic syndromes. | Nat Commun | 2017 |
| 28872462 | Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies. | J Clin Invest | 2017 |
| 28841212 | Impact of Notch disruption on myeloid development. | Blood Cancer J | 2017 |